BioHealth News Archive
Researchers in a Virginia Lab Lay Groundwork for U.S.-Made Drugs – Bloomberg
One thing both the Trump and Biden administrations have agreed on is that the U.S. needs to expand domestic manufacturing, and soon. The pharmaceutical…
Read More
Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer · BioBuzz
Gaithersburg, MD, Feb. 22, 2021 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company pioneering mRNA-engineered cell therapy in and beyond oncology, today announced that…
Read More
BioHealth Capital Region Women Making Waves in Venture Capital · BioBuzz
Improving access to venture capital for life science entrepreneurs and emerging biopharma companies in the BioHealth Capital Region (BHCR) is a top priority. However,…
Read More
Where Americans Are Moving — and Why They Really Are Doing It
There's an old joke about economists that I've always liked. A junior professor goes to his senior colleague with a brilliant new idea. The…
Read More
5 Questions with Destinie Burgan, Upstream Supervisor of Manufacturing, Emergent BioSolutions · BioBuzz
“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little…
Read More
Inova Health System, University of Virginia open Northern Virginia campus – Washington Business Journal
The program, first conceived in 2016, puts the Charlottesville institution in Greater Washington and creates a new talent pool for the Falls Church-based organization.…
Read More
Innovation alliance unveils new name and strategic plan for Western Virginia | Business Local | roanoke.com
Astrategic alliance has a new name — Verge — and a new vision of acting as the front door for an innovation economy that…
Read More
Rockville-based Pediametrix receives $1M from National Science Foundation for R&D – Technical.ly DC
A Rockville, Maryland-based startup bringing AI and computer vision tools to pediatric health received nearly $1 million for R&D in a grant from the…
Read More
VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-19, 2021 (2)
Partnering meeting slots now are full with more than 450 1:1 partnering meetings requested with Program Officers from NSF, NIH and its individual institutes…
Read More
VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-19, 2021
Are you a biohealth company with innovative technology seeking funds to advance your commercialization activities? Do not miss a unique opportunity to discuss your…
Read More
Here is a summary and thank you to all participants and speakers of the VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-19, 2021
More than 160 entrepreneurs attended last week’s BHI Virtual Non-Dilutive Funding Workshop with 1:1 Partnering cohosted by BioHealth Innovation and Montgomery County Economic Development…
Read More
Dr. Dipanjan Pan and Phil Robilotto of the University of Maryland, Baltimore, join Rich Bendis on BioTalk
Dr. Dipanjan Pan and Phil Robilotto of the University of Maryland, Baltimore, join BioTalk to discuss RNA Disease Diagnostics, UM Ventures, and the commercialization…
Read More
IonQ, a quantum computing startup, will go public – Washington Business Journal
The 6-year-old company will merge with a blank-check firm to go public. {iframe}https://www.bizjournals.com/washington/news/2021/03/08/ionq-quantum-computing-startup-will-go-public.html{/iframe}
Read More
FASTER (Federal Authority for Science, Technology, Engineering and Research) Federal Labs: Leveraging Place, Talent and Technology
The federal lab system is an enormous $50 billion-plus enterprise of internal research and development taking place in federal facilities across the United States.…
Read More
GSK to receive CARB-X funding to develop superbug vaccines – EPM Magazine
GSK Biologicals and its affiliate GSK Vaccines Institute for Global Health (GVGH) are currently working on two vaccine projects. The first is to prevent…
Read More